Kohgo Y, Kato J, Nakaya R, Mogi Y, Yago H, Sakai Y, Matsushita H, Niitsu Y
Department of Internal Medicine, Sapporo Medical College, Japan.
Hybridoma. 1993 Oct;12(5):591-8. doi: 10.1089/hyb.1993.12.591.
Monoclonal antibodies (MoAbs) were produced by immunizing BALB/c mice with asialoglycoprotein receptor (AGPR) purified from human liver. The purity of AGPR was confirmed by SDS-polyacrylamide gel electrophoresis and by amino acid sequence. An enzyme-linked immunoassay revealed 24 monoclonal antibodies which reacted with human AGPR. By Western blot analysis, all antibodies recognized the 46 kDa human AGPR under the non-reduced conditions and four MoAbs recognized reduced protein. Two MoAbs reacted with AGPR derived from rat, rabbit and mouse liver under both non-reduced and reduced conditions, suggesting that we could obtain antibodies which reacted with AGPR epitopes shared by different species. In immunohistochemical studies, 30201-MoAb reacted with human liver tissue but not with other tissues. This antibody immunoprecipitated two major bands of 46 kDa and 39 kDa from [35S]-methionine metabolically labeled human hepatoma HepG2 cells. The determinant recognized by 30201-MoAb is a common epitope of AGPR which is present in different species and in both the precursor and maturation forms of the receptor.
用从人肝脏中纯化的去唾液酸糖蛋白受体(AGPR)免疫BALB/c小鼠,制备单克隆抗体(MoAbs)。通过SDS-聚丙烯酰胺凝胶电泳和氨基酸序列确定了AGPR的纯度。酶联免疫分析显示有24种单克隆抗体与人AGPR发生反应。通过蛋白质印迹分析,所有抗体在非还原条件下均能识别46 kDa的人AGPR,4种单克隆抗体能识别还原后的蛋白。两种单克隆抗体在非还原和还原条件下均能与来源于大鼠、兔和小鼠肝脏的AGPR发生反应,这表明我们能够获得与不同物种共有的AGPR表位发生反应的抗体。在免疫组织化学研究中,30201-MoAb与人肝脏组织发生反应,但不与其他组织发生反应。该抗体从[35S]-甲硫氨酸代谢标记的人肝癌HepG2细胞中免疫沉淀出46 kDa和39 kDa的两条主要条带。30201-MoAb识别的决定簇是AGPR的一个共同表位,存在于不同物种以及受体的前体和成熟形式中。